🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
Multiple sclerosis is the most common inflammatory disease of the central n...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-10-01
Trial ID
NCT04767698
Treatments Being Tested
The primary aim of this project is to determine whether there are differenc...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-11-18
Trial ID
NCT05131984
Treatments Being Tested
This pilot study will establish a proof of concept for using a systems biol...
Status
Completed
Location
Providence Neurological Specialties West
Start Date
2020-05-11
Trial ID
NCT05081700
Treatments Being Tested
The purpose of this Phase 3b study is to assess the efficacy, safety and to...
Status
Recruiting
Location
Perseverance Research Center
Start Date
2025-06-23
Trial ID
NCT06846281
Treatments Being Tested
This is a multicenter non-inferiority study, designed to establish non-infe...
Status
Active Not Recruiting
Location
Haukeland University Hospital
Start Date
2020-11-02
Trial ID
NCT04578639
Treatments Being Tested
The purpose of this prospective, multicenter, open-label, efficacy, and saf...
Status
Completed
Location
St George Hospital
Start Date
2016-09-09
Trial ID
NCT02861014
Treatments Being Tested
The specific aims of the study are: Primary: To determine the presence and...
Status
Recruiting
Location
Brigham MS Center, 60 Fenwood Road
Start Date
2016-05-02
Trial ID
NCT02649985
Treatments Being Tested
The proposed study is a pilot study of ublituximab involving people with mu...
Status
Recruiting
Location
Johns Hopkins University
Start Date
2026-02-10
Trial ID
NCT07389590
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Ocreliz...
Status
Completed
Location
Qaem International Hospital
Start Date
2019-08-19
Trial ID
NCT04966338
Treatments Being Tested